Jean Jacques Bienaime, Director at Immunome Inc. (IMNM), bought 5,000 shares at $20.70 ($104K) on 2026-05-15, disclosed to the SEC on 2026-05-19.
Open-market purchase of $104k IMNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |